SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CPHD - Cephid
CPHD 52.950.0%Nov 8 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who wrote (1)4/11/2002 6:40:35 PM
From: Ron   of 8
 
*DJ Cepheid Gets Two US Patents Covering I-CORE DNA Detection
DJ Cepheid/Patents -2: Detects Up To 4 Nucleic Acids -
SUNNYVALE, Calif. (Dow Jones)--Cepheid (CPHD) received two U.S. patents
covering its I-CORE module technology for DNA detection and the automated
preparation of biological samples using chip-based microfluidics technology.

In a press release Thursday, the biotechnology company said the I-CORE
module, a key component in Cepheid's DNA testing and analysis systems, has an
optical analysis system which can excite and detect up to four nucleic acids
simultaneously.

Cepheid has 36 U.S. patents issued or pending, plus corresponding foreign
patent applications.

Cepheid, developing and marketing integrated systems for DNA detection, had
revenue of $11.4 million in 2001.

The company's shares closed Thursday on Nasdaq at $3.70, up 41 cents, or
12.5%, on volume of 749,200 shares. Average daily trade volume is 593,498
shares.

Company Web Site: cepheid.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext